Publications by authors named "J Gimenez-Duran"

During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza vaccine effectiveness (IVE) against any influenza type to be 70% (95% confidence interval (CI): 51 to 81%) for primary care patients with acute respiratory illness (ARI) and 77% (95% CI: 21 to 93%) for hospitalised patients with severe ARI. In primary care, where most subtyped viruses (61%; 145/237) were A(H1N1), adjusted IVE was 77% (95% CI: 56 to 88%) against A(H1N1)pdm09.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed data from Spain's surveillance system for severe acute respiratory infections to assess the effect of nirsevimab on infants born from April 1, 2023, onward.
  • Researchers compared actual RSV hospitalizations in children under one year old from late 2023 to early 2024 with expected numbers based on previous seasons.
  • The results showed a significant reduction in hospitalizations, estimating between 9,364 to 9,875 fewer cases, which represents a 74% to 75% decrease in RSV-related hospitalizations.
View Article and Find Full Text PDF

In February 2023, German public health authorities reported two dengue cases (one confirmed, one probable) and four possible cases who travelled to Ibiza, Spain, in late summer/autumn 2022; the infection was probably acquired through mosquito bites. Case 1 visited Ibiza over 1 week in late August with two familial companions; all three developed symptoms the day after returning home. Only Case 1 was tested; dengue virus (DENV) infection was confirmed by presence of NS1 antigen and IgM antibodies.

View Article and Find Full Text PDF

Setting: Tuberculosis (TB) control requires accurate knowledge of TB incidence, but few studies have been published on TB incidence using individual data from drug prescriptions.

Objective: To measure the estimated completeness of regional surveillance system data before and after adding data from anti-tuberculosis drug prescriptions.

Design: We compiled data on all individuals who received specific anti-tuberculosis drugs from three sources-the passive surveillance system, the active surveillance system and the anti-tuberculosis drug prescription database-in the Balearic Islands, Spain, between 2010 and 2012.

View Article and Find Full Text PDF

The tuberculosis surveillance system in the Balearic Islands was assessed from 2005 to 2007. Applying the capture-recapture method the completeness of this system was evaluated to be 58.4%.

View Article and Find Full Text PDF